John D. Mendlein

Founder at Fate Therapeutics, Inc.

John D. Mendlein

John D. Mendlein

Founder at Fate Therapeutics, Inc.

Overview
Career Highlights

Aurora Biosciences Corp.
aTyr Pharma, Inc.
Adnexus

RelSci Relationships

2093

Number of Boards

19

Birthday

1960

Age

61

Relationships
RelSci Relationships are individuals John D. Mendlein likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Moderna, Inc.

Relationship likelihood: Strong

Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Partner at Polaris Partners

Relationship likelihood: Strong

Director & Chief Executive Officer at Moderna, Inc.

Relationship likelihood: Strong

Founder at Fate Therapeutics, Inc.

Relationship likelihood: Strong

Former Director-Corporate Ventures at Genentech, Inc.

Relationship likelihood: Strong

Managing Partner at Flagship Pioneering

Relationship likelihood: Strong

Professor at Harvard University

Relationship likelihood: Strong

Entrepreneur at Polaris Partners

Relationship likelihood: Strong

Managing Partner at Flagship Pioneering

Relationship likelihood: Strong

Paths to John D. Mendlein
Potential Connections via
Relationship Science
You
John D. Mendlein
Founder at Fate Therapeutics, Inc.
Education
B.S. in Biology

The University of Miami is a private research university in Coral Gables, Florida. As of 2019, the university enrolls 17,811 students in 12 separate colleges/schools, including the Leonard M. Miller School of Medicine in Miami's Health District, a law school on the main campus, and the Rosenstiel School of Marine and Atmospheric Science focused on the study of oceanography and atmospheric sciences on Virginia Key, with research facilities at the Richmond Facility in southern Miami-Dade County. The university offers 132 undergraduate, 148 master's, and 67 doctoral degree programs, of which 63 are research/scholarship and four professional areas of study. Over the years, the university's students have represented all 50 states and close to 150 foreign countries. With more than 16,000 full- and part-time faculty and staff, UM is a top 10 employer in Miami-Dade County. UM's main campus in Coral Gables has 239 acres and over 5.7 million square feet of buildings. Research is a component of each academic division, with UM attracting $358.9 million in sponsored research grants in FY 2019. UM offers a large library system with over 3.9 million volumes and exceptional holdings in Cuban heritage and music. UM also offers a wide range of student activities, including fraternities and sororities, a student newspaper and a radio station. UM's intercollegiate athletic teams, collectively known as the Miami Hurricanes, compete in Division I of the National Collegiate Athletic Association. UM's football team has won five national championships since 1983 and its baseball team has won four national championships since 1982.

JD

The University of California's Hastings College of the Law (UC Hastings or Hastings) is a top tier public law school in San Francisco, California, located in the Civic Center neighborhood. Founded in 1878 by Serranus Clinton Hastings, the first Chief Justice of California, it was the first law school of the University of California and was one of the first law schools established in the Western United States. It is the oldest law school on the West Coast. It is also one of the few university-affiliated law schools in the United States that does not share its campus with undergraduates or other graduate programs.

Ph.D Physiology

UCLA's primary purpose as a public research university is the creation, dissemination, preservation and application of knowledge for the betterment of our global society. To fulfill this mission, UCLA is committed to academic freedom in its fullest terms: We value open access to information, free and lively debate conducted with mutual respect for individuals, and freedom from intolerance. In all of our pursuits, we strive at once for excellence and diversity, recognizing that openness and inclusion produce true quality. These values underlie our three institutional responsibilities. Learning and teaching at UCLA are guided by the belief that undergraduate, graduate and professional school students and their teachers belong to a community of scholars. This community is dedicated to providing students with a foundational understanding of a broad range of disciplines followed by the opportunity for in-depth study in a chosen discipline. All members of the community are engaged together in discovering and advancing knowledge and practice. Learning occurs not only in the classroom but also through engagement in campus life and in communities and organizations beyond the university.

Career History
Executive Partner
2019 - Current

Flagship Pioneering seeks investment opportunities in companies located globally. The firm focuses on companies operating in the fields of therapeutics, life science tools & diagnostics, and bioenergy or cleantech. It provides financing for seed, early, and later-stage capital requirements. It acts as a lead investor. It also makes co-investments.

Founder
Current

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products include immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.

Founder & Board Member
Current

Homes for Sudan (HS4S) is focused on education for entrepreneurship as well as the superadobe earth-building method by Calearth.

Boards & Committees
Director
2003 - 2004

ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases.

Chairman & Chief Executive Officer
2000 - 2005

Affinium Pharmaceuticals Ltd. is a holding company, which engages in the provision of clinical development of antibacterial. It specializes in hte development of antibiotics that targets the bacterial fatty acid synthesis pathway. It focuses on small molecule antibacterials targeting FabI, an essential enzyme in the bacterial fatty acid cycle. The company was founded in 2000 and is headquartered in Austin, TX.

Director & Chief Knowledge Officer
1996 - 2001

Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA.

Scientific Advisory Board Member
Tenure Unconfirmed

Ocean Discovery Institute is a nonprofit company headquartered in San Diego, CA. The firm provides science education services.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$5,000 - $55K
2014

Ocean Discovery Institute is a nonprofit company headquartered in San Diego, CA. The firm provides science education services.

$75 - $149
2013

TO PROTECT AND RESTORE THE RESOURCES OF THE SAN ELIJO LAGOON ECOLOGICAL RESERVE.

$75 +
2012

TO PROTECT AND RESTORE THE RESOURCES OF THE SAN ELIJO LAGOON ECOLOGICAL RESERVE.

Political Donations
$1,100
2010

Senator from Washington

Transactions
Details Hidden

aTyr Pharma, Inc. raised money in a private placement transaction

Details Hidden

aTyr Pharma, Inc. raised money in a private placement transaction

Investments
Details Hidden

aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. It operates in a single accounting segment. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Details Hidden

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products include immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by John D. Mendlein. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of John D. Mendlein's profile does not indicate a business or promotional relationship of any kind between RelSci and John D. Mendlein.